{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:06:40Z","timestamp":1792264000333,"version":"4.4.0"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,3,5]],"date-time":"2002-03-05T00:00:00Z","timestamp":1015286400000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:sec><jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Aims<\/jats:bold> To examine risk factors associated with non\u2010fatal heroin overdose, particularly frequency and route of heroin administration.<\/jats:p><jats:p><jats:bold>Design<\/jats:bold> Data from cross\u2010sectional surveys were analysed as a case\u2013control and as a case cross\u2010over design.<\/jats:p><jats:p><jats:bold>Setting and participants<\/jats:bold> 2556 subjects treated for heroin dependence in 164 outpatient facilities in Spain.<\/jats:p><jats:p><jats:bold>Measurements<\/jats:bold> Prevalence of overdose involving emergency care in the 12 months before treatment admission.<\/jats:p><jats:p><jats:bold>Case control design<\/jats:bold> Odds ratio (OR) adjusted by logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case\u2013crossover design<\/jats:title><jats:p>Estimated relative risk (RR) of transient risk of injecting heroin.<\/jats:p><jats:p><jats:bold>Findings<\/jats:bold> The prevalence of overdose was 10%. In the case control analysis the cumulative risk of overdose increased as the frequency of heroin use decreased. However, among daily heroin users this risk increased as the frequency of heroin injection rose, with an OR of 6.0 (95% CI: 3.9\u20139.6) for daily injectors versus non\u2010injectors. Sniffers had a higher risk than smokers among non\u2010daily users, but not among daily users. Other factors associated with increased risk of overdose were: tranquillizers, alcohol or cocaine use, living in certain regions and being long\u2010term HIV+ 0. In the case\u2013crossover analysis, the RR for injecting heroin versus using other routes immediately before overdose was 15.9 (95%CI: 9.5\u201326.6), and was much higher for non\u2010daily heroin users than for daily users.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> These findings suggest that the rapid entry of a large quantity of heroin into the blood (as occurs when injecting) involves a high risk of overdose, especially when the heroin tolerance level is low (as occurs in sporadic users).<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1360-0443.2002.00058.x","type":"journal-article","created":{"date-parts":[[2003,3,10]],"date-time":"2003-03-10T10:22:49Z","timestamp":1047291769000},"page":"319-327","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Factors associated with non\u2010fatal heroin overdose: assessing the effect of frequency and route of heroin administration"],"prefix":"10.1111","volume":"97","author":[{"given":"M. Teresa","family":"Brugal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis De La","family":"Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Regidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Royuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Suelves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,3,5]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0213-9111(99)71331-2"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.9545698.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1996.9134059.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1996.91341310.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(99)00147-7"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1996.911217652.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.87.5.851"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02895.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.85.1.102"},{"key":"e_1_2_6_11_1","first-page":"646","article-title":"Prevalencia de infecci\u00f3n por el virus de la inmunodeficiencia humana y de conductas de riesgo entre los consumidores de hero\u00edna de Barcelona, Madrid y Sevilla: un ejemplo de las ventajas de centrar los estudios en los consumidores y no s\u00f3lo en los usuarios por v\u00eda intravenosa [Prevalence of human immunodeficiency virus infection and risk behaviors in heroin users of Barcelona, Madrid and Seville: an example of the advantages of centering studies on users and not just on intravenous users].","volume":"113","author":"De La Fuente L.","year":"1999","journal-title":"Medicina Cl\u00ednica (Barcelona)"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(95)01208-7"},{"key":"e_1_2_6_13_1","volume-title":"Sistema Estatal de Informaci\u00f3n sobre Toxicoman\u00edas (SEIT) Informe a\u00f1o 1995 [State Information System on Drug Abuse (SEIT) 1995 Report].","author":"Delegaci\u00f3n Del Gobierno Para El Plan Nacional Sobre Dogas","year":"1996"},{"key":"e_1_2_6_14_1","volume-title":"Informe no. 3. Observatorio Espa\u00f1ol sobre Drogas, Marzo 2000.","author":"Delegaci\u00f3n Del Gobierno Para El Plan Nacional Sobre Dogas","year":"2000"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7054.402"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.2307\/2530643"},{"key":"e_1_2_6_17_1","first-page":"1","article-title":"Mortality and cause of death among drug users received in treatment in 1996.","volume":"3","author":"Haastrup L.","year":"1999","journal-title":"Nye Tal Fra Sundheldsstyrelsen"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9422216.x"},{"key":"e_1_2_6_19_1","volume-title":"Epidemiological Research: Principles and Quantitative Methods.","author":"Kleinbaum D. G.","year":"1982"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115853"},{"key":"e_1_2_6_21_1","volume-title":"Epidemiologic Trends in Drug Abuse, vol. I: Highlights and Executive Summary.","author":"National Institute On Drug Abuse (Nida)","year":"1998"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/25.3.545"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9444712.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(97)00196-0"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-7-199904060-00019"},{"key":"e_1_2_6_26_1","first-page":"673","article-title":"Heroin smoking by \u2018chasing the dragon\u2019: origins and history.","volume":"91","author":"Strang J.","year":"1996","journal-title":"Addiction"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)10101-5"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7069.1400b"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/09652149640518"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826089909037245"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4603(98)00083-5"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008752"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9479612.x"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1360-0443.2002.00058.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1360-0443.2002.00058.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1360-0443.2002.00058.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:09:10Z","timestamp":1698782950000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1360-0443.2002.00058.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1046\/j.1360-0443.2002.00058.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1360-0443.2002.00058.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"2002-03-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}